BTC Health Limited (BTC.AX)
AUD 0.05
(-8.0%)
AUD 0.05
(-8.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 1.05 Million AUD | 110.38% |
| 2023 | -10.16 Million AUD | -1665.01% |
| 2022 | -576.07 Thousand AUD | -47.08% |
| 2021 | -391.68 Thousand AUD | -38.39% |
| 2020 | -283.03 Thousand AUD | 54.46% |
| 2019 | -692.74 Thousand AUD | 10.17% |
| 2018 | -466.01 Thousand AUD | -41.93% |
| 2017 | -516.52 Thousand AUD | -235.86% |
| 2016 | -170.78 Thousand AUD | 29.89% |
| 2015 | -207.01 Thousand AUD | -37.09% |
| 2014 | -151 Thousand AUD | 44.05% |
| 2013 | -122.69 Thousand AUD | -8.47% |
| 2012 | -302.99 Thousand AUD | 42.27% |
| 2011 | -894 Thousand AUD | 51.24% |
| 2010 | -565 Thousand AUD | -9.0% |
| 2009 | -508 Thousand AUD | 17.58% |
| 2008 | -7.37 Million AUD | 16.75% |
| 2007 | -825 Thousand AUD | 5.29% |
| 2006 | -397 Thousand AUD | 9.17% |
| 2005 | -1.57 Million AUD | 37.86% |
| 2004 | - AUD | -182.74% |
| 2003 | -782 Thousand AUD | 3.94% |
| 2002 | -814.1 Thousand AUD | 13.67% |
| 2001 | -943 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -595.59 Thousand AUD | 0.0% |
| 2024 Q2 | 1.65 Million AUD | 0.0% |
| 2024 FY | 1.05 Million AUD | 110.38% |
| 2023 FY | -10.16 Million AUD | -1665.01% |
| 2023 Q4 | -9.9 Million AUD | 0.0% |
| 2023 Q2 | -258 Thousand AUD | 0.0% |
| 2022 FY | -576.08 Thousand AUD | -47.08% |
| 2022 Q4 | -219.22 Thousand AUD | 0.0% |
| 2022 Q2 | -356.86 Thousand AUD | 0.0% |
| 2021 FY | -391.69 Thousand AUD | -38.39% |
| 2021 Q4 | -212.74 Thousand AUD | 0.0% |
| 2021 Q2 | -183.94 Thousand AUD | 0.0% |
| 2020 Q4 | -61.75 Thousand AUD | 0.0% |
| 2020 FY | -283.04 Thousand AUD | 54.46% |
| 2020 Q2 | -221.29 Thousand AUD | 0.0% |
| 2019 Q4 | -447.16 Thousand AUD | 0.0% |
| 2019 FY | -621.47 Thousand AUD | 10.17% |
| 2019 Q2 | -203.42 Thousand AUD | 0.0% |
| 2018 FY | -691.84 Thousand AUD | -41.93% |
| 2018 Q2 | -566.82 Thousand AUD | 0.0% |
| 2018 Q4 | -125.01 Thousand AUD | 0.0% |
| 2017 Q2 | -172.61 Thousand AUD | 0.0% |
| 2017 FY | -487.45 Thousand AUD | -235.86% |
| 2017 Q4 | -314.84 Thousand AUD | 0.0% |
| 2016 Q4 | -90.82 Thousand AUD | 0.0% |
| 2016 Q2 | -54.31 Thousand AUD | 0.0% |
| 2016 FY | -145.13 Thousand AUD | 29.89% |
| 2015 FY | -207.01 Thousand AUD | -37.09% |
| 2015 Q4 | -102.32 Thousand AUD | 0.0% |
| 2015 Q2 | -104.69 Thousand AUD | 0.0% |
| 2014 Q4 | -68.03 Thousand AUD | 0.0% |
| 2014 FY | -151 Thousand AUD | 44.05% |
| 2014 Q2 | -82.97 Thousand AUD | 0.0% |
| 2013 Q4 | -74.21 Thousand AUD | -9.98% |
| 2013 Q2 | -157.97 Thousand AUD | -153.96% |
| 2013 Q3 | -67.47 Thousand AUD | 57.29% |
| 2013 Q1 | -62.2 Thousand AUD | 0.0% |
| 2013 FY | -269.89 Thousand AUD | -8.47% |
| 2012 Q4 | -62.2 Thousand AUD | 0.0% |
| 2012 Q2 | -62.2 Thousand AUD | 42.27% |
| 2012 Q1 | -107.75 Thousand AUD | 0.0% |
| 2012 FY | -248.81 Thousand AUD | 42.27% |
| 2012 Q3 | -62.2 Thousand AUD | 0.0% |
| 2011 Q3 | -107.75 Thousand AUD | 0.0% |
| 2011 FY | -431 Thousand AUD | 51.24% |
| 2011 Q4 | -107.75 Thousand AUD | 0.0% |
| 2011 Q2 | -107.75 Thousand AUD | 51.24% |
| 2011 Q1 | -221 Thousand AUD | 0.0% |
| 2010 Q2 | -221 Thousand AUD | -9.0% |
| 2010 Q3 | -221 Thousand AUD | 0.0% |
| 2010 Q4 | -221 Thousand AUD | 0.0% |
| 2010 FY | -884 Thousand AUD | -9.0% |
| 2010 Q1 | -202.75 Thousand AUD | 0.0% |
| 2009 Q4 | -202.75 Thousand AUD | 0.0% |
| 2009 Q1 | -246 Thousand AUD | 0.0% |
| 2009 Q2 | -202.75 Thousand AUD | 17.58% |
| 2009 Q3 | -202.75 Thousand AUD | 0.0% |
| 2009 FY | -811 Thousand AUD | 17.58% |
| 2008 Q1 | -295.5 Thousand AUD | 0.0% |
| 2008 Q4 | -246 Thousand AUD | 0.0% |
| 2008 Q3 | -246 Thousand AUD | 0.0% |
| 2008 FY | -984 Thousand AUD | 16.75% |
| 2008 Q2 | -246 Thousand AUD | 16.75% |
| 2007 Q4 | -295.5 Thousand AUD | 0.0% |
| 2007 Q3 | -295.5 Thousand AUD | 0.0% |
| 2007 Q2 | -295.5 Thousand AUD | 5.29% |
| 2007 Q1 | -312 Thousand AUD | 0.0% |
| 2007 FY | -1.18 Million AUD | 5.29% |
| 2006 Q2 | -312 Thousand AUD | 9.17% |
| 2006 Q3 | -312 Thousand AUD | 0.0% |
| 2006 FY | -1.24 Million AUD | 9.17% |
| 2006 Q4 | -312 Thousand AUD | 0.0% |
| 2006 Q1 | -343.5 Thousand AUD | 0.0% |
| 2005 Q1 | -552.75 Thousand AUD | 0.0% |
| 2005 Q4 | -343.5 Thousand AUD | 0.0% |
| 2005 FY | -1.37 Million AUD | 37.86% |
| 2005 Q3 | -343.5 Thousand AUD | 0.0% |
| 2005 Q2 | -343.5 Thousand AUD | 37.86% |
| 2004 Q1 | -195.5 Thousand AUD | 0.0% |
| 2004 Q2 | -552.75 Thousand AUD | -182.74% |
| 2004 FY | -2.21 Million AUD | -182.74% |
| 2004 Q4 | -552.75 Thousand AUD | 0.0% |
| 2004 Q3 | -552.75 Thousand AUD | 0.0% |
| 2003 Q3 | -195.5 Thousand AUD | 0.0% |
| 2003 FY | -782 Thousand AUD | 3.94% |
| 2003 Q1 | -203.52 Thousand AUD | 0.0% |
| 2003 Q2 | -195.5 Thousand AUD | 3.94% |
| 2003 Q4 | -195.5 Thousand AUD | 0.0% |
| 2002 Q1 | -235.75 Thousand AUD | 0.0% |
| 2002 Q4 | -203.52 Thousand AUD | 0.0% |
| 2002 FY | -814.1 Thousand AUD | 13.67% |
| 2002 Q2 | -203.52 Thousand AUD | 13.67% |
| 2002 Q3 | -203.52 Thousand AUD | 0.0% |
| 2001 Q4 | -235.75 Thousand AUD | 0.0% |
| 2001 Q2 | -235.75 Thousand AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | -943 Thousand AUD | 0.0% |
| 2001 Q3 | -235.75 Thousand AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 120.056% |
| Acrux Limited | -9.83 Million AUD | 110.731% |
| Race Oncology Limited | -13.38 Million AUD | 107.887% |
| Biome Australia Limited | -1.91 Million AUD | 155.157% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 107.179% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 108.573% |
| CSL Limited | 5.64 Billion AUD | 99.981% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 102.356% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 97.853% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 89.139% |
| Hexima Limited | -1 Million AUD | 204.613% |
| Immutep Limited | -44.93 Million AUD | 102.348% |
| Memphasys Limited | -2.7 Million AUD | 139.027% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 99.533% |
| Noxopharm Limited | -7.53 Million AUD | 114.005% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 114.684% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 102.235% |
| Starpharma Holdings Limited | -15.15 Million AUD | 106.961% |
| Tissue Repair Ltd | -4.87 Million AUD | 121.643% |
| Biotron Limited | -5.15 Million AUD | 120.486% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 105.384% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 172.323% |
| Bio-Gene Technology Limited | -3.06 Million AUD | 134.459% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 117.771% |
| Patrys Limited | -3.53 Million AUD | 129.818% |
| Orthocell Limited | -11.68 Million AUD | 109.034% |
| Imugene Limited | -140.93 Million AUD | 100.749% |
| PYC Therapeutics Limited | -38.85 Million AUD | 102.716% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 114.593% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 111.981% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 114.671% |
| Nanollose Limited | -1.24 Million AUD | 184.435% |
| Invex Therapeutics Ltd | -2.13 Million AUD | 149.46% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | 151.313% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 123.848% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | 136.721% |
| Nyrada Inc. | -4.56 Million AUD | 123.141% |
| Telix Pharmaceuticals Limited | - AUD | -Infinity% |
| Dimerix Limited | -25.05 Million AUD | 104.211% |
| PharmAust Limited | -6.65 Million AUD | 115.848% |
| AnteoTech Limited | -11.72 Million AUD | 108.999% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 101.621% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 104.786% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 122.995% |
| Actinogen Medical Limited | -12.83 Million AUD | 108.219% |
| Immuron Limited | -5.8 Million AUD | 118.191% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 118.608% |